-+ 0.00%
-+ 0.00%
-+ 0.00%

Arbutus Biopharma announces annual general and special shareholders meeting

PUBT·04/14/2026 21:03:29
Listen to the news
Arbutus Biopharma announces annual general and special shareholders meeting
  • Arbutus Biopharma set its annual general and special shareholder meeting for May 26, 2026 in Vancouver, British Columbia.
  • Shareholders will vote to elect five directors to serve until 2027.
  • Meeting will also consider adoption of 2026 Omnibus Share and Incentive Plan, reserving 16,300,000 common shares for issuance.
  • Advisory vote is scheduled on compensation for named executive officers.
  • Shareholders will vote on appointment of Ernst & Young as independent registered public accounting firm for fiscal 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arbutus Biopharma Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-014623), on April 14, 2026, and is solely responsible for the information contained therein.